Does Doxylamine Succinate And Pyridoxine Hydrochloride Delayed Re Interact with Monoamine Oxidase Inhibitors Maois?
CDI records a contraindicated classification for Doxylamine Succinate And Pyridoxine Hydrochloride Delayed Re and Monoamine Oxidase Inhibitors Maois. The stored summary is: Use is contraindicated in women taking MAOIs, which prolong and intensify the anticholinergic (drying) effects of antihistamines. The mechanism involves maois prolong and intensify anticholinergic effects of antihistamines. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Contraindicated
- Management
- Do not take together
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
MAOIs prolong and intensify anticholinergic effects of antihistamines
What To Tell Your Doctor or Pharmacist
If you are taking Doxylamine Succinate And Pyridoxine Hydrochloride Delayed Re and your doctor is considering prescribing Monoamine Oxidase Inhibitors Maois (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask about alternative medications that do not interact with your current regimen
- Ask how frequently you should be monitored while these are co-prescribed
- Never stop or change either medication without first consulting your healthcare provider